VBL Final Phase 1/2 Study Results Presented at ASCO Demonstrate VB-111 Dose Dependent Increase in Overall Survival and 58% CA-125 Response Rate in Platinum-Resistant Ovarian Cancer

Stacey Gandler
Brand Nourishment

Paul Theisen
Patient Acquisition

Liz Kane
Impactful Strategy

Matthew Durham
Omnidynamic Marketing

Brenda Snow
Authentic Patient Voice

Bud Bilanich
Success Coach

Pat Purcell
Meeting Engagement

David Linetsky
Point-of-Care Marketing

Daniel Sontupe
Market Access

Amy Giles
Increasing Engagement

Joey Cohen
Medication Adherence

Matt Turner
Patient Affordability

Frank Burrell
Scientific Storytelling

Suma Ramadas, PhD
Medical Affairs